Intra Cellular Therapies shares owned by Natixis Asset Management Advisors
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Natixis Asset Management Advisors
from 13F filings
Historical chart of Natixis Asset Management Advisors investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by Natixis Asset Management Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by Natixis Asset Management Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.8M | 25k | 73.18 |
| 2024-06-30 | $2.2M | 32k | 68.48 |
| 2024-03-31 | $2.4M | 35k | 69.19 |
| 2023-12-31 | $2.4M | 34k | 71.62 |
| 2023-09-30 | $1.6M | 31k | 52.08 |
| 2023-06-30 | $2.1M | 34k | 63.32 |
| 2023-03-31 | $1.5M | 28k | 54.15 |
| 2022-12-31 | $1.5M | 27k | 52.94 |
| 2022-09-30 | $977k | 21k | 46.51 |
| 2022-06-30 | $1.1M | 19k | 57.07 |
| 2022-03-31 | $1.1M | 18k | 61.22 |
| 2021-12-31 | $555k | 11k | 52.32 |
| 2020-12-31 | $342k | 11k | 31.79 |
More positions owned by Natixis Asset Management Advisors
View all positions for Natixis Asset Management Advisors